PCK2 and breast carcinoma: Evidence from breast cancer cells has shown that knockdown of PEPCK, which converts oxaloacetate to PEP, reduces cell growth and increases cell death under stress conditions,42 suggesting that PEP may play a prosurvival role in trophoblasts.